CSIMarket
 


Purple Biotech Ltd   (PPBT)
Other Ticker:  
 
 

PPBT's Income from Cont. Operations Growth by Quarter and Year

Purple Biotech Ltd 's Income from Cont. Operations results by quarter and year




PPBT Income from Cont. Operations (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 21.76 18.47 28.07 5.89
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   21.76 18.47 28.07 5.89



PPBT Income from Cont. Operations fourth quarter 2022 Y/Y Growth Comment
Purple Biotech Ltd reported Income from Cont. Operations increase of 17.81% year on year in the fourth quarter 2022, to $ 21.76 millions, this is lower than Purple Biotech Ltd 's recent average Income from Cont. Operations rise of 91.46%.

Looking into fourth quarter 2022 results within Major Pharmaceutical Preparations industry 13 other companies have achieved higher Income from Cont. Operations growth. While Purple Biotech Ltd ' s Income from Cont. Operations growth of 17.81% ranks overall at the positon no. 822 in the fourth quarter 2022.




PPBT Income from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December 17.81 % -34.2 % 376.57 % 5.75 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   17.81 % -34.2 % 376.57 % 5.75 %

Financial Statements
Purple Biotech Ltd 's fourth quarter 2022 Income from Cont. Operations $ 21.76 millions PPBT's Income Statement
Purple Biotech Ltd 's fourth quarter 2021 Income from Cont. Operations $ 18.47 millions Quarterly PPBT's Income Statement
New: More PPBT's historic Income from Cont. Operations Growth >>


PPBT Income from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   17.81 % -34.2 % 376.57 % 5.75 %




Income from Cont. Operations fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #14
Healthcare Sector #51
Overall #822

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
376.4 % 91.46 % -34.22 %
(Dec 31 2020)   (Dec 31 2021)
Income from Cont. Operations fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #14
Healthcare Sector #51
Overall #822
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
376.4 % 91.46 % -34.22 %
(Dec 31 2020)   (Dec 31 2021)

Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Purple Biotech Ltd 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PPBT's IV. Quarter Q/Q Income from Cont. Operations Comment


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PPBT's IV. Quarter Q/Q Income from Cont. Operations Comment


Purple Biotech Ltd 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Jun 30 2019)
Cumulative Income from Cont. Operations 12 Months Ending $ 21.76 $ 18.47 $ 28.07 $ 5.89 $ 0.00
Y / Y Income from Cont. Operations Growth (TTM) 17.83 % -34.22 % 376.4 % 5.82 % -
Year on Year Income from Cont. Operations Growth Overall Ranking # 822 # 0 # 0 # 0 # 1333
Seqeuential Income from Cont. Operations Change (TTM) 17.83 % -34.22 % 376.4 % 5.82 % -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 822 # 0 # 0 # 0 # 1642




Cumulative Income from Cont. Operations growth Comment
Although Purple Biotech Ltd 's Annual Income from Cont. Operations growth year on year were below company's average 91.46% , Income from Cont. Operations announced in the Dec 31 2022 period, show improvement in Income from Cont. Operations trend, to cumulative trailing twelve month growth of 17.83% year on year, from -34.22% in Dec 31 2021.

In the Healthcare sector 50 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 0 to 822.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
376.4 %
91.46 %
-34.22 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 14
Healthcare Sector # 51
Overall # 822

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
376.4 %
91.46 %
-34.22 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 51
S&P 500 # 822
Cumulative Income from Cont. Operations growth Comment
Although Purple Biotech Ltd 's Annual Income from Cont. Operations growth year on year were below company's average 91.46% , Income from Cont. Operations announced in the Dec 31 2022 period, show improvement in Income from Cont. Operations trend, to cumulative trailing twelve month growth of 17.83% year on year, from -34.22% in Dec 31 2021.

In the Healthcare sector 50 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 0 to 822.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
376.4 %
91.46 %
-34.22 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 14
Healthcare Sector # 51
Overall # 822

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
376.4 %
91.46 %
-34.22 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 14
Sector # 51
S&P 500 # 822




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
PPBT's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for PPBT's Competitors
Income from Cont. Operations Growth for Purple Biotech Ltd 's Suppliers
Income from Cont. Operations Growth for PPBT's Customers

You may also want to know
PPBT's Annual Growth Rates PPBT's Profitability Ratios PPBT's Asset Turnover Ratio PPBT's Dividend Growth
PPBT's Roe PPBT's Valuation Ratios PPBT's Financial Strength Ratios PPBT's Dividend Payout Ratio
PPBT's Roa PPBT's Inventory Turnover Ratio PPBT's Growth Rates PPBT's Dividend Comparisons



Companies with similar Income from Cont. Operations growth for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Dec 31 2022
Vericel Corporation30.58%$ 30.584 millions
Pfizer Inc29.93%$ 29.930 millions
Bruker Corporation29.34%$ 29.342 millions
Cadre Holdings inc 24.37%$ 24.369 millions
Alpha Tau Medical ltd 23.80%$ 23.802 millions
Neurocrine Biosciences Inc 22.25%$ 22.253 millions
Staar Surgical Company18.92%$ 18.915 millions
Edwards Lifesciences Corporation18.82%$ 18.819 millions
Purple Biotech Ltd 17.83%$ 17.825 millions
United Therapeutics Corporation17.74%$ 17.736 millions
Integra Lifesciences Holdings Corp16.66%$ 16.662 millions
Electromed Inc 16.59%$ 16.587 millions
Mettler Toledo International Inc15.14%$ 15.144 millions
Option Care Health Inc 14.98%$ 14.979 millions
Addus Homecare Corporation13.05%$ 13.049 millions
Eli Lilly And Company12.26%$ 12.259 millions
Resmed Inc 11.48%$ 11.481 millions
Zoetis Inc 11.38%$ 11.380 millions
Check cap Ltd 11.08%$ 11.080 millions
Utah Medical Products Inc10.26%$ 10.261 millions
Exicure Inc 9.92%$ 9.919 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Š 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071